Junsheng Ma, Ph.D.

2013 Biostatistics The University of Texas School of Public Health 
Biostatistics Biology, Epidemiology, Behavioral Psychology
"Junsheng Ma"


Sign in to add mentor
Wenyaw Chan grad student 2013 The University of Texas School of Public Health
 (A bayesian approach to longitudinal categorical data in a continuous time markov chain model.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Patel R, Ma J, Bashir Q, et al. (2021) Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to whites: a propensity-score matched analysis. American Journal of Hematology
Zou J, Kongtim P, Oran B, et al. (2021) Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation. Haematologica
Liu Z, Ma J, Jimenez C, et al. (2021) Pheochromocytoma: A Clinicopathologic and Molecular Study of 390 Cases From a Single Center. The American Journal of Surgical Pathology
Williams MD, Ma J, Grubbs EG, et al. (2021) loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma. American Journal of Cancer Research. 11: 3227-3239
Wang J, Ma J, Cai C, et al. (2021) A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rules. Statistics in Medicine
Joseph J, Ma J, Hennawy F, et al. (2021) Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma. Transplantation and Cellular Therapy. 27: 404.e1-404.e5
Martinez-Zayas G, Almeida FA, Yarmus L, et al. (2021) Predicting Lymph Node Metastasis in Non-Small Cell Lung Cancer: Prospective External and Temporal Validation of the HAL and HOMER Models. Chest
Bagheri-Yarmand R, Dadu R, Ye L, et al. (2021) ONC201 shows anti-cancer activity against medullary thyroid cancer via transcriptional inhibition of RET, VEGFR2, and IGFBP2. Molecular Cancer Therapeutics
Jimenez C, Subbiah V, Stephen B, et al. (2020) Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas. Cancers. 12
Tetzlaff MT, Adhikari C, Lo S, et al. (2020) Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology
See more...